Robert Wren
Acute Care · Kingwood, TXNPI 1508295460
Payments from drug & device makers
Across 312 payments — averaging $23.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biohaven Pharmaceuticals, Inc.$1K
- GSK$1K
- AstraZeneca$900
- Pfizer$867
- Lilly USA, LLC$757
- AbbVie$630
- plus $2K from 24 others
What the payments were for
- Consulting fees$1,20016%
- Food & beverage$6,19384%
- Education$230%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biohaven Pharmaceuticals, Inc. | 1 | $1,200 |
| GSK | 59 | $1,059 |
| AstraZeneca | 25 | $900 |
| Pfizer | 41 | $867 |
| Lilly USA, LLC | 44 | $757 |
| AbbVie | 41 | $630 |
| Novo Nordisk | 35 | $567 |
| Linus Health, Inc. | 1 | $210 |
| Amgen | 11 | $165 |
| Exact Sciences | 8 | $146 |
| Abbott | 5 | $107 |
| Amarin Pharma, Inc. | 6 | $102 |
| Inspire Medical Systems, Inc. | 3 | $100 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $98 |
| Astellas Pharma US Inc | 4 | $93 |
| Boehringer Ingelheim | 4 | $67 |
| Merck | 4 | $54 |
| Bayer | 2 | $37 |
| Sumitomo Pharma America, Inc. | 2 | $36 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $35 |
| Seqirus USA Inc | 1 | $28 |
| Optinose US, Inc. | 1 | $24 |
| Mylan Specialty L.p. | 1 | $21 |
| Azurity Pharmaceuticals, Inc. | 1 | $21 |
| Corcept Therapeutics | 1 | $18 |
| Antares Pharma, Inc. | 1 | $16 |
| Edwards Lifesciences | 1 | $16 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $14 |
| Shield Therapeutics Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$1,200
- CORE COGNITIVE EVALUATION$210
- AIRSUPRA$123
- BREZTRI$101
How this compares
$7,417 in reported general payments places this provider in the 95th percentile of 2,323 acute care providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 46 | $47,802 |
| FarxigaDapagliflozin Propanediol | 16 | $22,685 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 31 | $19,172 |
| MounjaroTirzepatide | 13 | $16,095 |
| JardianceEmpagliflozin | 14 | $9,086 |
| Humulin 70/30 KwikpenInsulin Nph Hum/Reg Insulin Hm | 17 | $2,735 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $1,605 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 37 | $832 |
| Azelastine Hcl | 32 | $796 |
| Bupropion XlBupropion Hcl | 28 | $759 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 24 | $691 |
| Metoprolol Succinate | 25 | $680 |
| Gabapentin | 37 | $658 |
| Atorvastatin Calcium | 62 | $611 |
| Losartan Potassium | 46 | $581 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $567 | $47,80246 claims |
| AstraZenecaFarxiga | $900 | $22,68516 claims |
| GSKTrelegy Ellipta | $1,059 | $19,17231 claims |
| Lilly USA, LLCMounjaro | $757 | $16,09513 claims |
| Boehringer IngelheimJardiance | $67 | $9,08614 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,323 acute care providers in Texas.
Other acute care in Kingwood
- Jennifer PilotteDallas$232K
- Christie MorrisonSan Antonio$225K
- Amanda BradleyDallas$85K
- Laura WilsonEl Paso$32K
- Kim HuynhCypress$29K
- Martha LibertyDallas$28K
- Afton DickersonHouston$27K
- Eleanor WeltgeHouston$25K
- Leslie GutierrezHouston$25K
- Bahia ElkamandSugar Land$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.